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Abstract:  
Repeated cold stress (RCS) is known to transiently induce functional disorders associated with hypotension 
and hyperalgesia. In this study, we investigated the effects of RCS (24°C and 4°C alternately at 30 min intervals 
during the day and 4°C at night for two days, followed by 4°C on the next two consecutive nights) on the 
thresholds for cutaneous mechanical pain responses and on peripheral expression of “pain-related genes” in 
SHRSP5/Dmcr rats, which are derived from stroke-prone spontaneously hypertensive rats. To define genes 
peripherally regulated by RCS, we detected changes in the expression of pain-related genes in dorsal root 
ganglion cells by PCR-based cDNA subtraction analysis or DNA microarray analysis, and confirmed the changes 
by RT-PCR. We found significantly changed expression in eight pain-related genes (up-regulated: Fyn, St8sia1, 
and Tac1; down-regulated: Ctsb, Fstl1, Itpr1, Npy, S100a10). At least some of these genes may play key roles in 
hyperalgesia induced by RCS.  
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Introduction 
When repeatedly exposed to a cold environment, animals show functional disorders associated with 
hypotension [1,2] and facilitated responses to noxious stimuli; namely, transient decreases in the nociceptive 
threshold to chemical, heat, and pressure stimuli [3-7]. This stress model, called repeated cold stress (RCS) or 
specific alteration of rhythm in environmental temperature (SART) stress, is considered to be a chronic pain 
model. The hyperalgesia in this model lasts for several days after cessation of RCS [6,7]. This hyperalgesia is 
thought to be induced by hypofunction of endogenous pain inhibitory systems that modulate pain sensation in 
the central nervous system [8]. However, some peripheral mechanisms may be also responsible for this 
hyperalgesia. Studies focusing on peripheral regulation of pain are needed to clarify the mechanisms underlying 
the hyperalgesia induced by RCS.  
Spontaneously hypertensive rats (SHR) and stroke-prone spontaneously hypertensive rats (SHRSP) are 
established as parallel lines from outbred Wistar-Kyoto rats (WKY). SHR is reported to be more insensitive to 
mechanical pain than WKY [9]. SHRSP5/Dmcr rats are a substrain of SHRSP [10], so we expected that obvious 
hyperalgesia would be induced by RCS in SHRSP5/Dmcr rats, owing to their high pain threshold. 
In this study, we investigated the effects of RCS on the thresholds of cutaneous mechanical pain responses 
and on changes in expression of pain-related genes in dorsal root ganglion cells (DRGs) in SHRSP5/Dmcr rats. 
We focused on the “pain-related genes” contained in the Pain Genes Database [11]. To determine the gene 
expression changes accompanied by RCS, we performed PCR-based cDNA subtraction, “suppression subtractive 
hybridization” and DNA microarray analysis of mRNAs from DRGs of SHRSP5/Dmcr rats. The gene expression 
changes detected by these analyses were confirmed by reverse transcription polymerase chain reaction (RT-PCR). 
There are no reported investigations of pain responses in SHRSP5/Dmcr rats. Thus, we compared the 
cutaneous mechanical pain thresholds and blood pressures of SHRSP5/Dmcr rats with those of Wistar and 
Sprague-Dawley (SD) rats.  
A preliminary account of this experiment has been reported elsewhere [12]. 
 
Materials and Methods 
 
Animals 
Adult male SHRSP5/Dmcr rats (10-24 weeks old at the start of the experiments, n=28), adult male Slc:Wistar rats 
(8-15 weeks old, n=8), and adult male SD rats (7-14 weeks old, n=8) were used. They were kept on a 12 h 
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alternating light-dark cycle (light between 8:00 and 20:00). The animals were housed in groups of three at 24°C 
with food and water available ad libitum. All rats were fed with a normal diet (CE-2, CLEA Japan, Inc.) throughout 
the experiment. All animal procedures were approved by the Experimental Animal Research Committee of Kinjo 
Gakuin University and conducted in accordance with its Animal Experiment Guidelines. 
 
Measurement of pain threshold 
 
Animals were placed in wire bottom cages, allowing access to the underside of their paws. The cutaneous 
mechanical pain threshold was measured by hind paw withdrawal response to von Frey hair (VFH) test. VFHs 
(diameter: 0.5 mm) of different strength were applied in ascending order of force (bending forces 21.9~348 g/mm2 
in quasi-logarithmic order). Each VFH was applied five times perpendicularly to the mid-plantar surface of the 
one hind paw for 1-2 s and the number of withdrawal responses immediately upon application of the stimulus was 
noted. The pain threshold was defined as the minimum force at which the animal showed at least four withdrawal 
responses in response to five stimuli. 
 
Repeated cold stress exposure 
 
RCS was applied to SHRSP5/Dmcr rats according to a modified method, reducing one cold night, based 
upon the protocol described by Satoh et al. [6]. Briefly, the rats were kept at 4°C from 16:30 on the first day (Day 
0) to 10:00 the following morning and then alternately exposed to room temperature (24°C) and cold temperature 
4°C at 30 minute intervals from 10:00 to 16:30 (Day 1). These procedures were repeated on Day 2. From the 
evening of Day 2 until the morning of Day 4, the rats were exposed to 4°C between 16:30 and 10:00 (Fig. 1). The 
stress exposures were carried out in separate rooms. Initially, we observed the effects of RCS on the pain threshold 
and blood pressure 2 or 3 days a week from 7 days before to 18 days after starting RCS (n=4) (long-term follow-
up study). Then we observed the effects of RCS on the pain threshold and blood pressure from 7 days before to 4 
days after starting RCS (n=12), and conducted a comparison with an age-matched control rat group kept at 24°C 
throughout the experiment (n=12) (short-term follow-up study). To blind the evaluators as to which group an 
animal belonged to in the short-term follow-up study, control rats were mixed with the RCS rat group and measured 
at the same time.  
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Measurement of blood pressure 
 
Blood pressure was measured using an indirect blood pressure meter (BP-98A, Softron, Japan) according to 
the tail pulse method. Changes in systolic blood pressure appeared to be in parallel directions with diastolic blood 
pressure. Calculated mean arterial blood pressure (MBP) data were recorded.   
 
Tissue dissection and extraction of total RNAs  
 
At the end of the short-term follow-up study, the rats were deeply anesthetized with sodium pentobarbital 
(100 mg/kg, i.p.) and transcardially perfused with diethylpyrocarbonate (DEPC)-treated saline. The DRGs (L3-
L6) were dissected. These tissues were immediately frozen in liquid nitrogen and stored at -80°C until RNA 
extraction. 
Total RNAs were extracted from DRGs with RNeasyTM Plus Mini Kit (Qiagen). RNA purity was routinely 
assessed by measuring the 260 nm/280 nm ratio of the sample. These samples were analyzed by DNA microarray 
analysis, PCR-based cDNA subtraction, and RT-PCR. 
 
Pain Genes Database  
 
We focused on the “pain-related genes” after filtering against the Pain Genes Database [11], which is a 
comprehensive catalog of genes implicated in pain sensitivity through mouse transgenic knockout studies. The 
database contains over 250 pain-related genes. The data of PCR-based cDNA subtraction and DNA microarray 
analysis were filtered using this database.  
 
PCR-based cDNA subtraction 
 
The total RNA samples (1 µg each) taken from two animals’ DRGs in the control group and the RCS group, 
respectively, were combined. The first-strand cDNAs were synthesized using a SMARTerTM PCR cDNA Synthesis 
Kit (Clontech, CA, USA). PCR-based cDNA subtraction was conducted using a PCR-SelectTM cDNA Subtraction 
Kit (Clontech, CA, USA), which is based on the suppressive subtractive hybridization method. The suppressive 
hybridization method is able to detect small changes by the normalization of the abundance of cDNAs within the 
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target population and the subtraction of the common sequences between the test and control populations. The 
unhybridized sequences were amplified by PCR and cloned into the vector pGem-T EasyTM (Promega, WI, USA). 
The resultant plasmids were transformed into Escherichia coli strain JM109 and amplified, and then sequenced. 
Sequencing primers were as follows: (sense) M13FW, 5’-GTA AAA CGA CGG CCA GT-3’; (antisense) M13RV, 
5’-GGA AAC AGC TAT GAC CAT G-3’.  
 
DNA microarray analysis 
 
The total RNA samples (2 µg each) taken from two animal's DRGs of the control group and the RCS group, 
respectively, were combined. The cDNA microarray assay was done by Filgen Inc. (Aichi, Japan). The assays were 
performed on the platform of CodeLinkTM Rat Whole Genome Bioarray (Applied Microarray, Inc. AZ, USA), in 
which 33,849 oligonucleotide probes were spotted. The Pain Genes Database included 251 genes when we 
searched it. After excluding overlapping genes, the number of genes was 128. This microarray analysis could 
detect 113 out of 128 pain-related genes. The expression level of each gene was compared between the RCS and 
control groups. Differences were considered significant if the changes were smaller than four-tenths or greater 
than two-fold.  
 
RT-PCR 
 
The target mRNAs of RT-PCRs were those with expression changes detected by PCR-based cDNA 
subtraction or cDNA microarrays, and selected with Pain Genes Database. Total RNAs (1 µg) were reverse 
transcribed using oligo (dT)16 primer and M-MuLV reverse transcriptase (NEB, MA, USA), and the transcripts 
were amplified using sequence-specific primers for the genes and Taq DNA polymerase (NEB, MA, USA). 
Potions of PCR product mixtures were electrophoresed in an agarose gel and stained with ethidium bromide. The 
densities of the bands were quantified using the image analysis software Image J (version 1.47d) [13]. The 
expression levels were normalized to the expression levels of cyclophilin A (CypA, a house keeping gene) 
measured as an internal standard in each sample. Subsequently, amplicons were digested with restriction 
enzymes and the size of fragments was checked (data not shown). The sequences of PCR primers, PCR 
condition and size of products are shown in Table 1. 
Statistical analysis 
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The data are presented as mean ± SE, and were analyzed using the following statistical analyses or tests: 
Student’s t-test for unpaired observations, one-way repeated measures analysis of variance (ANOVA) followed 
by Bonferroni's multiple comparison test or Tukey's multiple comparison test, and two-way repeated measures 
ANOVA followed by Tukey's multiple comparison test. Differences were considered significant if p<0.05. 
 
Results 
 
Comparison of cutaneous mechanical pain thresholds and blood pressures of SHRSP5/Dmcr rats with those of 
Wistar and SD rats 
 
The mechanical pain thresholds and blood pressures of SHRSP5/Dmcr rats were compared with those of 
Wistar and SD rats (Fig. 2). The mechanical pain thresholds of SHRSP5/Dmcr rats (183.9±18.5 g/mm2) were 
significantly higher than those of Wistar rats (82.6±15.6 g/mm2) (p<0.05 by one-way repeated measures ANOVA 
followed by Tukey's multiple comparison test), and similar to those of SD rats (179.4±20.6 g/mm2). On the other 
hand, the mean blood pressures of SHRSP5/Dmcr rats (160.5±2.6 mmHg) were significantly higher than those 
of Wistar (103.5±2.2 mmHg) and SD rats (111.3±1.93 mmHg) (p<0.05 by one-way repeated measures ANOVA 
followed by Tukey's multiple comparison test). We found that both of the pain threshold and blood pressure of 
SHRSP5/Dmcr rats were high. 
 
Effects of repeated cold stress on the cutaneous mechanical pain threshold and blood pressure 
 
In the long-term follow-up study, the exposure of SHRSP5/Dmcr rats to RCS markedly decreased the 
mechanical pain threshold and blood pressure (n=4). Compared with Day 0, the pain threshold was significantly 
decreased at Day 4 and Day 7 (p<0.001 by one-way repeated measures ANOVA followed by Bonferroni's multiple 
comparison test), while the blood pressure was significantly decreased at Day 4 (p<0.01 by one-way repeated 
measures ANOVA followed by Bonferroni's multiple comparison test) (Fig. 3). The recovery of the RCS-induced 
decrease in pain threshold was slower than that of blood pressure. The greatest decreases in the pain threshold and 
blood pressure were seen at Day 4. Afterwards, the pain thresholds and blood pressure gradually returned to near 
the baseline level.  
 8 
To investigate changes in gene expression induced by RCS, we performed a short-term follow-up study in 
which we observed the effect of RCS on the pain threshold up to Day 4, after which the DRGs were dissected. In 
this short-term follow-up study, the pain thresholds were significantly decreased at Day 3 and Day 4 compared 
with the control (p<0.05 vs. corresponding control by two-way repeated measures ANOVA followed by Tukey's 
multiple comparison test, n=12) (Fig. 4).  
 
PCR-based cDNA subtraction 
 
We compiled both up-regulated and down-regulated cDNA sequences in the DRGs of RCS rats relative to 
those in the DRGs of control rats. The number of up- and down-regulated genes in the RCS rats was 20 and 44, 
respectively. In the up-regulated group, there was one known pain-related gene, Tac 1 (substance P), among the 
20 up-regulated genes. In the down-regulated group, there were three known pain-related genes, Ctsb (cathepsin 
B), Fstl1 (follistatin-like 1), and S100a10 (annexin 2 light), among the 44 down-regulated genes. These genes are 
listed in Table 2. 
 
DNA microarray analysis 
 
Using DNA microarray analysis, we detected changes in gene expression to identify genes affected by 
RCS. We compiled both up-regulated and down-regulated cDNA sequences in the DRGs of RCS rats that 
showed greater than twofold changes in expression relative to those of DRGs of control rats. The number of up- 
and down-regulated genes in the RCS rats was 381 and 314, respectively. In the up-regulated genes, there were 4 
pain-related genes, Fyn (Src kinase p59), Grin2b (glutamate ionotropic receptor), Map2k1 (mitogen activated 
protein kinase), and St8sia1 (GD3 synthase). In the down-regulated group, there were two pain-related genes, 
Itpr1 (inositol 1, 4, 5-triphosphate) and Npy (neuropeptide Y). These genes are listed in Table 2. The changes in 
expression of Ctsb, Fstl1, S100a10, and Tac 1 were not significant in this analysis with changes detected by 
PCR-based cDNA subtraction.  
 
Changes in gene expression levels detected by RT-PCR 
 
PCR-based cDNA subtraction analysis and DNA microarray analysis detected up- or down-regulation of 
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ten pain-related genes (Ctsb, Fstl1, Fyn, Grin2b, Itpr1, Map2k1, Npy, S100a10, St8sia1, and Tac 1). Among 
these genes, the expression changes were confirmed by RT-PCR. The expression levels of Fyn, St8sia1, and Tac 
1 at Day 4 were significantly increased, and those of Ctsb, Fstl1, Itpr1, Npy, and S100a10 were significantly 
decreased, as shown in Fig. 5 (p<0.05, p<0.01, or p<0.001 vs. control by Student’s t-test, n=12, respectively). 
The fold changes of gene expression in Grin2b and Map2k1were 0.91±0.12 and 1.03±0.09, respectively, and 
these differences were not significant.  
 
Discussion 
The pain thresholds in SHRSP5/Dmcr rats were similar to those in SD rats, while the mean blood pressures 
in SHRSP5/Dmcr rats were significantly higher than those in SD rats. It is thought that there is no direct 
relationship between pain thresholds and blood pressures. In SHRSP5/Dmcr rats hyperalgesia was also shown to 
be induced by RCS in a manner similar to that in SD rats [6]. SHRSP5/Dmcr rats were shown to develop 
hypercholesterolemia in response to a high-fat diet over two weeks [10]. However, in this study, all SHRSP5/Dmcr 
rats were fed a normal diet before and during the experiment. We consider the pain response in SHRSP5/Dmcr 
rats fed a normal diet to be similar to that in SD rats. We tried to apply RCS to SHRSP5/Dmcr rats under the 
modified condition reported by Satoh et al. As expected, obvious hyperalgesia and hypotension were induced by 
RCS in SHRSP5/Dmcr rats. 
RCS is considered to be a chronic pain model caused by imbalance in the autonomic nervous system, 
specifically vagotonia or decreased activity of the sympathetic nervous system [4,14]. This hyperalgesia is thought 
to be induced by hypofunction of endogenous pain inhibitory systems, which modulate the pain sensation in the 
central nervous system [8]. The central nervous system functions associated with "pain perception and processing" 
are complex [15,16]; therefore, many regions, including the hypothalamus, is speculated to be involved in 
hyperalgesia from RCS. However, some peripheral mechanisms may be also responsible for this hyperalgesia. In 
this study, we focused on RCS-induced peripheral regulation of pain sensation and analyzed several pain-related 
genes in DRGs using cDNA subtraction and DNA microarray analysis. We observed for the first time changes in 
the expression of pain-related genes induced by RCS in DRG using DNA microarray and/or cDNA subtraction 
analysis.   
RCS model animals have been produced by changing the temperature from 24°C to 4°C (RCS at 4°C) in 
ddY mice [17] and from 24°C to -3°C (RCS at -3°C) in Wistar rats [1]. Mechanical hyperalgesia has been induced 
by RCS in Wistar rats [5] and in SD rats (RCS at 4°C) [6,7]. In this study, we observed obvious hyperalgesia and 
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hypotension in SHRSP5/Dmcr rats after the end of RCS, which was alternately 24°C and 4°C at 30 min intervals 
during the day and 4°C at night for two days, followed by 4°C on two consecutive nights.  
Immediately after RCS, the mechanical pain threshold was significantly decreased. Obvious decreases in 
pain threshold and blood pressure were induced by RCS. Afterwards, the pain threshold and blood pressure 
gradually returned to near the baseline level. The recovery rate of the pain threshold was slower than that of blood 
pressure. Pain sensation might be strongly influenced by RCS. 
PCR-based cDNA subtraction is able to detect even slight changes in gene expression, but is not 
quantitative. Using PCR-based cDNA subtraction and RT-PCR, we detected up-regulation of Tac 1 (substance 
P), and down-regulation of Ctsb (Cathepsin B), Fstl1 (follistatin-like 1), and S100a10 (annexin 2 light) (Table 2, 
Fig. 4).  
Substance P, coded by Tac 1, is known to be released from both central and peripheral terminals of primary 
afferent sensory neurons, transmitting nociceptive information. Satoh et al. suggested that enhanced synaptic 
transmission mediated by substance P and calcitonin gene-related peptide in the spinal dorsal horn is, at least in 
part, involved in hyperalgesia due to RCS [6]. In this study, changes in expression of calcitonin gene-related 
peptide were not detected. 
Follistatin-like 1, coded by Fstl1, is secreted from sensory afferent axons and activates presynaptic Na+/K+-
ATPase, leading to membrane hyperpolarization. Deletion of Fstl1 in DRG neurons induces enhances afferent 
synaptic transmission and sensory hypersensitivity [18]. Fstl1 plays an important role in suppression of 
nociceptive afferent transmission and its reduction in primary afferent neurons, resulting in pain hypersensitivity.  
Cathepsin B, coded by Ctsb, is thought to be an essential enzyme for the induction of chronic 
inflammatory pain, inducing the maturation and secretion of IL-1β and IL-18 by spinal microglia [19]. The 
reduced expression of Ctsb may provide a protective adaptation to RCS. 
S100a10, coding annexin 2 light chain, is involved in the trafficking of the voltage-gated sodium channel 
Nav1.8, which is a sensory neuron-specific voltage-gated sodium channel [20,21]. Reduced expression of 
S100a10 may therefore also provide a protective adaptation to RCS. 
Furthermore, using DNA microarray analysis and RT-PCR, we detected up-regulation of St8sia1 (GD3 
synthase) and Fyn (Src kinase p59), and down-regulation of Itpr1 (inositol 1,4,5-triphosphate) and Npy 
(neuropeptide Y) (Table 2, Fig. 4). 
Src-family protein tyrosine kinases coded by the Fyn phosphorylate NR2B subunit of the NMDA receptor 
increase synaptic currents [22], leading to central sensitization in the spinal dorsal horn.  
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Knockdown of NPY produces rapid and reversible increases in the intensity and duration of tactile and 
thermal hypersensitivity [23]. NPY is thought to inhibit the spinal transmission of sensory signals. RCS induces 
a decrease in NPY expression in DRG and subsequent excitation of DRG, leading to hyperalgesia.  
Inositol 1,4,5-triphosphate receptor (IP3R1) coded by Itpr1 is a specific intracellular calcium release 
channel protein, which is observed in the central and peripheral nervous systems [24]. Increased calcium ion 
influx induces hyperexcitability of nociceptive sensory neurons. Calcium released from IP3R1-gated stores may 
participate in modulating presynaptic function [25], and reduced expression of IP3R1 may induce hyperalgesia.  
GD3 synthase, coded by St8sia1, produces ganglioside, which is important as a component of lipid rafts and 
serves as a key for cell-cell interactions and signal transduction complexes in peripheral nociceptor endings [26]. 
LaCroix-Fralish et al. performed a meta-analysis of twenty microarray studies of neuropathic or 
inflammatory pain [27]. They found that Reg3b (regenerating islet-derived 3 beta; pancreatitis-associated protein) 
and Ccl2 (chemokine [C-C motif] ligand 2) were significantly up-regulated in every neuropathic or inflammatory 
pain condition in the rat and proposed these two genes as potential biomarkers of chronic pain. Of these two genes, 
only Ccl2 is listed in the Pain Genes Database [11]. In this study, there was no significant change in expression of 
Ccl2 with RCS. Here, we look at Tac 1 and Npy, which were up-regulated and down-regulated, respectively, by 
RCS in this study. In LaCroix-Fralish's paper, Tac 1 and Npy, along with many other genes, are listed as being 
upregulated mainly by neuropathy. That is, Tac 1 was up-regulated by RCS or neuropathy, while Npy was down-
regulated by RCS and up-regulated by neuropathy. It is thought that participating pain-related genes depend on the 
type of pain. Fyn, St8sia1, Ctsb, Fstl1, Itpr1, and S100a10, which were up/down-regulated by RCS, are not listed 
in LaCroix-Fralish's paper. 
It has been reported that some genes are differentially expressed between different strains (SHR and WKY), 
and even between substrains from different sources [28]. Therefore, gene expression profiles in SHRSP5/Dmcr 
rats may be different from those in SD rats and WKY rats. In the present study, we revealed that Fyn, St8sia1 and 
Tac1 were up-regulated, and that Ctsb, Fstl1, Itpr1, Npy, and S100a10 were down-regulated by RCS in 
SHRSP5/Dmcr rats. We conclude that hyperalgesia induced by RCS is peripherally regulated by at least some of 
these genes, coordinated through modulation of signal transduction in peripheral nociceptor endings and synaptic 
transmission. Some of them may also be related to protective adaptation mechanisms to RCS.  
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FIGURE LEGENDS 
 
Fig. 1 Schematic representation of RCS exposure protocols. 
Rats were kept at 4°C from 16:30 on the first day (Day 0) to 10:00 the following morning and then 
alternately exposed to room temperature (24°C) and cold temperature 4°C at 30 minute intervals from 
10:00 to 16:30 (Day 1). These procedures were repeated on Day 2. From the evening of Day 2 until the 
morning Day 4, the rats were exposed to 4°C between 16:30 and 10:00. The pain threshold and blood 
pressure were measured before the start of RCS stress and at Day 3 and Day 4 after RCS. 
 
Fig.2 Pain thresholds and blood pressures of Slc:Wistar, SD, and SHRSP5/Dmcr rats. 
Each column and bar represent the mean and SE (n=8, respectively).  
* p<0.05 between strains by one-way repeated measures ANOVA followed by Tukey's multiple comparison 
test. 
 
Fig. 3 Changes in the pain threshold and blood pressure by RCS in the long-term follow-up study. 
The pain threshold (solid circles) and blood pressure (open circles) were measured from 7 days before to 
18 days after the start of the RCS, 2 or 3 days a week (n=4). 
Obvious decreases in pain threshold and blood pressure were induced by RCS. The recovery rate of the 
pain threshold was slower than that of blood pressure. 
* p<0.05, **p<0.01, ***p<0.001 vs. pre-RCS (Day 0) by one-way repeated measures ANOVA followed by 
Bonferroni's multiple comparison test.  
 
Fig. 4 Changes in pain threshold from RCS in the short-term follow-up study. 
The pain threshold was measured from 6 days before to 4 days after the start of RCS (solid circles) and 
compared with the controls (non-RCS, open circles) (n=12, respectively). Obvious decreases in pain 
threshold were induced by RCS. Each circle and bar represent the mean and SE.  
* p<0.05 vs. corresponding control by two-way repeated measures ANOVA followed by Tukey's multiple 
comparison test.  
 
Fig.5 Changes in gene expression of pain-related genes in DRGs induced by RCS. 
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Analysis of the pain-related gene expression levels in the control group (white bars) and RCS group (black 
bars) was performed using RT-PCR. Significant changes in expression of eight pain-related genes were 
observed.  
The values were normalized by the level of CypA. Each column and bar represent the mean and SE (n=12, 
respectively). *p<0.05, **p<0.01 and ***p<0.001 vs. control by Student’s t-test.  
Three representative images of each RT-PCR amplification in the control (left hand side) and RCS group 
(right hand side) are also shown, respectively. 
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Table 1  PCR primers, conditions and sizes of PCR products
Primer
Sense
Antisense
Ctsb cathepsinB BC072490
5’-GAAGCCATGTCTGACCGAAT-3’　
5’-CCACTGGGCCATTTTTGTAG-3’
60 28 406
Fstl1 follistatin-like 1 NM_024369
5’-GCCATGGAGACCTAACCAAA-3’
5’-TGAGGGACCTCTTGTGCTTT-3’
56 32 386
Fyn Src kinase p59 NM_012755
5’-GCTTGGATAATGGGCTGTGT-3’ 
5’-CATCTTCTGTCCGTGCTTCA-3’
60 34 306
Grin2b
glutamate ionotropic 
receptor
NM_012574
5’-CCCAAGTTCTGGTTGGTGTT-3’
5’-GATCTGAGCGATGGCTTCTT-3’
62 40 303
Itpr1 inositol1,4,5-triphosphate NM_001007235
5’-GGTTGTGAACTTAGCCAGGAAC-3’ 
5’-CTGGTACATTACTTGGCCCTTC-3’
58 36 481
Map2k1
mitogen activated protein 
kinase
NM_031643
5’-GCAAGATGCCCAAGAAGAAG-3’ 
5’-GATGATCTGGTTCCGGATTG-3’
60 34 339
Npy neuropeptide Y NM_012614
5’-GCTAGGTAACAAACGAATGGGG-3’ 
5’-CACATGGAAGGGTCTTCAAGC-3’
55 37 288
S100a10 protein S100-A10 (p11) BC091565
5’-TGCTCATGGAAAGGGAGTTC-3’ 
5’-GCTTGTCGAATTGGAGTTGG-3’
60 30 330
St8sia1 GD3 synthase NM_012813
5’-GGAAAGCCAAAGGTGTGTGT-3’ 
5’-GGTTGCAGCAGTCTTCCATT-3’
56 34 373
Tac 1 substance P NM_012666
5’-CGAGCAGTGAGCGGTAAAAT-3’　
5’-CGCAAGACACACAGGAGTTT-3’
60 27 305
CypA
peptidylprolyl isomerase A 
(cyclophilin A) 
(internal standard)
BC059141
5’- ACGCCGCTGTCTCTTTTC -3’ 
5’- TGCCTTCTTTCACCTTCC -3’ 
55 24 440
Temp (°C) 
1)
Cycle
2)
Size (bp)
3)
3) Size: sizes of PCR products 
1) Temp: Annealing temperature 
2) Cycle: PCR cycles
Gene 
name
Protein name Accession No.
Table1
Direction
(fold of 
increase or 
decrease)
Direction
Fold of 
changes
Ctsb cathepsinB subtraction Down Down 0.9
Fstl1 follistatin-like 1 subtraction Down Down 0.8
Fyn Src kinase p59 microarray Up (2.7) Up 1.7
Grin2b glutamate ionotropic receptor microarray Up (2.6) non -
Itpr1 inositol 1,4,5-triphosphate receptor, type 1 microarray Down (0.5) Down 0.6
Map2k1 mitogen activated protein kinase microarray Up (2.6) non -
Npy neuropeptide Y microarray Down (0.5) Down 0.7
S100a10 annexin 2 light subtraction Down Down 0.5
St8sia1 GD3 synthase microarray Up (2.4) Up 1.3
Tac 1 substance P subtraction Up Up 3
Microarray: DNA microarray analysis
Subtraction: PCR-based cDNA subtraction
Table 2  RT-PCR of the pain-related genes whose expression changes were detected by PCR-based cDNA 
subtraction or DNA microarray analysis 
Gene name Protein name Assay
RT-PCR
Table2
